CORRELATION BETWEEN DISEASE ACTIVITY AND SERUM TNF-ALPHA LEVELS IN PATIENTS WITH ANKYLOSING SPONDYLITIS

被引:0
|
作者
Kraev, K. [1 ,2 ]
Geneva-Popova, M. [1 ,3 ]
Popova, S. [1 ,3 ]
机构
[1] Med Univ Plovdiv, Propedeut Internal Dis, Plovdiv, Bulgaria
[2] Multiprofile Hosp Act Treatment Kaspela, Rheumatol, Plovdiv, Bulgaria
[3] Multiprofile Hosp Act Treatment St George, Rheumatol, Plovdiv, Bulgaria
关键词
D O I
10.1136/annrheumdis-2021-eular.931
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0489
引用
收藏
页码:1272 / 1272
页数:1
相关论文
共 50 条
  • [1] SERUM CYTOKINES (TNF-ALPHA AND IL-18) IN ANKYLOSING SPONDYLITIS IN RELATION TO DISEASE ACTIVITY
    Ivanova, Mariana
    Manolova, Irena
    Goycheva, Petia
    Stoilov, Rumen
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2014, 67 (04): : 593 - 602
  • [2] TNF-alpha inhibitors for ankylosing spondylitis
    Maxwell, Lara J.
    Zochling, Jane
    Boonen, Annelies
    Singh, Jasvinder A.
    Veras, Mirella M. S.
    Ghogomu, Elizabeth Tanjong
    Jandu, Maria Benkhalti
    Tugwell, Peter
    Wells, George A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (04):
  • [3] THE CORRELATION BETWEEN SERUM VITAMIN D LEVELS AND PARATHYROID HORMONE AND DISEASE ACTIVITY IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Baykal, Tuba
    Alp, Filiz
    Ugur, Mahir
    Erdal, Akin
    Melikoglu, Meltem
    Senel, Kazim
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 152 - 153
  • [4] Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors
    Monti, Sara
    Todoerti, Monica
    Codullo, Veronica
    Favalli, Ennio Giulio
    Biggioggero, Martina
    Becciolini, Andrea
    Montecucco, Carlomaurizio
    Caporali, Roberto
    MODERN RHEUMATOLOGY, 2018, 28 (03) : 542 - 549
  • [5] SUCCESSFUL DOSE REDUCTION OF TNF-ALPHA BLOCKING AGENTS IN ANKYLOSING SPONDYLITIS PATIENTS WITH STABLE LOW DISEASE ACTIVITY
    Arends, S.
    van der Veer, E.
    Kamps, F. B.
    Efde, M.
    Leijsma, M. K.
    Bootsma, H.
    Brouwer, E.
    Spoorenberg, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 517 - 517
  • [6] TNF-alpha antagonists for treatment of juvenile ankylosing spondylitis
    I Orbán
    K Sevcic
    EV Kiss
    Pediatric Rheumatology, 9 (Suppl 1)
  • [7] Serum levels of mmp-3 and cathepsin K in Ankylosing spondylitis patients, and evolution under anti tnf-alpha therapy
    Wendling, Daniel
    Cedoz, Jean Pierre
    Racadot, Evelyne
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S587 - S588
  • [8] BISPHENOL A LEVELS IN PATIENTS WITH ANKYLOSING SPONDYLITIS AND ITS CORRELATION WITH DISEASE ACTIVITY
    Ustun, N.
    Ustun, I.
    Yagiz, A. E.
    Okur, R.
    Turhanoqlu, A. D.
    Sungur, S.
    Gokce, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1030 - 1030
  • [9] Periodontal Disease Is Not Associated With Ankylosing Spondylitis and TNF-Alpha Blockers Usage In Korea
    Chang, Sung Hae
    Lee, Jung Tae
    Choi, Byoung Youg
    Cho, Hyon Joung
    Yoo, Jong Jin
    Oh, Hye Jin
    Kang, Eun Ha
    Song, Yeong Wook
    Lee, Hyo Jung
    Lee, Yun Jong
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1059 - S1059
  • [10] The influence of TNF-alpha polymorphisms on the susceptibility and severity of ankylosing spondylitis in Romanian patients
    Popa, O. M.
    Dutescu, M. I.
    Bojinca, M.
    Bojinca, V.
    Bara, C.
    Meirosu, M.
    Milicescu, M.
    Popa, L. O.
    TISSUE ANTIGENS, 2011, 77 (05): : 506 - 507